Peer-influenced content. Sources you trust. No registration required. This is HCN.
Cancer Care Business Exchange (CBEx)
Join Dr. Ira Klein at the CPC and CBEx Annual Congress as he demystifies AI in cancer care, providing practical insights and discussing future opportunities. Learn how AI can be harnessed to improve patient care, manage data, and streamline service requests.
Oncology, Medical August 7th 2023
Mayo Clinic
Join your peers at the GRIT for Women in Medicine: Growth, Resilience, Inspiration, & Tenacity 2023 conference. Together, you will develop a deeper understanding of the unique challenges women face in healthcare leadership and explore tangible, evidence-based strategies for success. Take this opportunity to earn credits, expand your professional network, and contribute to a more diverse, effective, and resilient healthcare system. Register today.
All Specialties July 25th 2023
Clinical Advisor
Find out more about the concerning trend in the treatment of uncomplicated UTIs at emergency departments, and discover why so many patients may not be receiving the IDSA-recommended treatment.
Emergency Medicine July 20th 2023
Oncology Learning Network
The results of the WU-KONG6 study offer hope for NSCLC patients with EGFR exon20 insertion mutations, demonstrating the substantial antitumor efficacy of sunvozertinib.
Oncology, Medical July 3rd 2023
Cancer Therapy Advisor
The study findings suggest that acalabrutinib and rituximab, a chemo-free therapy option, may offer a new standard of care for older, untreated MCL patients, with promising early complete responses. Yet, more data is needed to understand long-term safety and risk of relapse.
Hematology/Oncology July 3rd 2023
FIL-ROUGE trial data presented at the International Conference on Malignant Lymphoma 2023 highlight the potential of intensified ABVD in improving outcomes for untreated Hodgkin lymphoma patients. Further exploration of this regimen’s long-term toxicity is anticipated.